Sardonyx Solutions Inc., a U.S.-based Contract Research Organization (https://sardonyxsol.com/) specializing in pharmacovigilance and drug safety, is pleased to announce a strategic partnership with ETL Pharmacovigilance Center, an internationally recognized provider of end-to-end pharmacovigilance services.
This partnership brings together two highly specialized teams committed to patient safety, regulatory compliance, and operational excellence in drug safety. The collaboration will combine Sardonyx’s global infrastructure and regulatory expertise with ETL’s continuous, compliant, and scalable pharmacovigilance service model.
The joint effort will focus on:
- Robust ICSR processing and safety reporting
- High-quality literature screening and signal detection
- Aggregate report preparation and medical review
- Strengthened local and global compliance coverage
ETL’s strategic location bridging Europe and Asia ensures around-the-clock safety monitoring, while Sardonyx provides regulatory leadership and operational excellence from its U.S. base and global hubs.
This partnership is an important step forward in delivering responsive, efficient, and scalable pharmacovigilance services tailored to the needs of biopharma companies at every stage of product development and commercialization.
20 May 2025
No responses yet